The metabolic index [FBG, HbA1c (%), homeostatic model assessment of insulin resistance (HOMA-IR), TG, and BMI], CAP value, and inflammatory parameters [white blood cells, high-sensitivity C-reactive protein, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α)] of the treated group were significantly improved compared with those of the untreated group. Here, IL6 is linked to Insulin resistance.